Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
miR-124-enriched MSC Exosomes in Acute Ischemic Stroke
NCT03384433Phase 2Unknown
- Start
- Apr 2019
- Primary completion
- Jun 2021
- Modality
- Lipid-based Nanoparticles, Cell Therapies, RNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of microRNA-124-enriched mesenchymal stem cell-derived exosomes in ischemic stroke. Status: unknown.
02
Drugs
microRNA-124-enriched mesenchymal stem cell-derived exosomes
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03384433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384433.